Fulcrum Therapeutics, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US3596161097
USD
8.76
-0.19 (-2.12%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
243.03
235.19
198.94
211.54
95.18
87.15
Shareholder's Funds
243.03
235.19
198.94
211.54
95.18
87.15
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
2.19
2.19
2.60
0.00
0.02
0.05
Secured Loans
2.19
2.19
2.60
0.00
0.02
0.05
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
6.64
8.83
11.02
4.26
7.67
11.15
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
6.64
8.83
11.02
4.26
7.67
11.15
Current Liabilities
Trade Payables
1.16
2.76
3.64
4.79
4.08
2.19
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
11.04
13.68
16.73
19.20
26.73
12.14
Total Liabilities
260.72
257.69
226.69
235.00
129.58
110.44
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
23.84
25.15
26.63
15.64
14.52
13.15
Less: Accumulated Depreciation
14.26
12.76
10.66
8.27
6.12
3.95
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
9.58
12.39
15.97
7.37
8.40
9.21
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
1.20
1.09
1.09
1.09
1.09
1.09
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.01
2.01
2.10
0.54
0.58
0.06
Total Non-Current Assets
10.80
15.50
19.17
9.00
10.07
10.36
Current Assets Loans & Advances
Current Investments
182.81
210.66
167.82
182.75
55.86
0.00
Inventories
0.00
0.00
0.00
0.00
0.00
0.00
Sundry Debtors
2.10
0.54
0.23
3.64
2.53
0.00
Cash and Bank
58.21
25.56
35.10
35.41
57.05
96.71
Other Current Assets
244.36
238.47
204.00
222.27
115.62
96.82
Short Term Loans and Advances
1.25
1.71
0.85
0.47
0.18
0.00
Total Current Assets
249.92
242.20
207.52
226.00
119.51
100.08
Net Current Assets (Including Current Investments)
238.88
228.52
190.79
206.80
92.78
87.94
Total Current Assets Excluding Current Investments
249.92
242.20
207.52
226.00
119.51
100.08
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
260.72
257.69
226.69
235.00
129.58
110.44
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
2.19
2.19
2.60
0.00
0.02
0.05
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

No Borrowings in the last few periods;

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2024 is -24.80% vs -19.87% in Dec 2023

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2024 is -22.68% vs -22.42% in Dec 2023

stock-summary

Investments

YoY Growth in year ended Dec 2024 is 10.09% vs 0.00% in Dec 2023

stock-summary

Current Assets

YoY Growth in year ended Dec 2024 is 3.19% vs 16.71% in Dec 2023

Compare Balance Sheet Results of Fulcrum Therapeutics, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
243.03
285.15
-42.12
-14.77%
Shareholder's Funds
243.03
285.15
-42.12
-14.77%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
2.19
0.86
1.33
154.65%
Secured Loans
2.19
0.86
1.33
154.65%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0
0.00
0.00%
Other Long Term Liabilities
6.64
2.35
4.29
182.55%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
6.64
2.35
4.29
182.55%
Current Liabilities
Trade Payables
1.16
1.94
-0.78
-40.21%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
11.04
7.11
3.93
55.27%
Total Liabilities
260.72
294.61
-33.89
-11.50%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
23.84
3.25
20.59
633.54%
Less: Accumulated Depreciation
14.26
0.08
14.18
17,725.00%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
9.58
3.17
6.41
202.21%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
1.20
0.45
0.75
166.67%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
0.01
0.45
-0.44
-97.78%
Total Non-Current Assets
10.80
4.07
6.73
165.36%
Current Assets Loans & Advances
Current Investments
182.81
0
182.81
0.00%
Inventories
0
0
0.00
0.00%
Sundry Debtors
2.10
0
2.10
0.00%
Cash and Bank
58.21
285.06
-226.85
-79.58%
Other Current Assets
244.36
285.06
-40.70
-14.28%
Short Term Loans and Advances
1.25
0
1.25
0.00%
Total Current Assets
249.92
290.54
-40.62
-13.98%
Net Current Assets (Including Current Investments)
238.88
283.43
-44.55
-15.72%
Total Current Assets Excluding Current Investments
249.92
290.54
-40.62
-13.98%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
260.72
294.61
-33.89
-11.50%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
2.19
0.86
1.33
154.65%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Markets Mojo
No Borrowings in the last few periods
stock-summary

No Borrowings in the last few periods;

Annual - Other Long Term Liabilities
Other Long Term Liabilities 6.64 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -24.80% vs -19.87% in Dec 2023

Annual - Fixed Assets
Fixed Assets 9.58 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -22.68% vs -22.42% in Dec 2023

Annual - Investments
Investments 1.20 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 10.09% vs 0.00% in Dec 2023

Annual - Current Assets
Current Assets 249.92 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 3.19% vs 16.71% in Dec 2023